POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No91/2015
Date of issue:2015-09-28
Short name of the issuer
SOPHARMA AD
Subject
Current report 91 - Notification
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors of SOPHARMA AD (the “Company") hereby informs that in order to facilitate the operational work of Sopharma AD, the Board of Directors decided to appoint Ivan Badinski, MPharm, director of Cooperation and Licenses, Sopharma AD as procurator of the company. Mr. Badinski has been working in Sopharma AD since 1997 as a member of the Board of Directors of the Company. At the end of 1997 he became its Chief Commercial Officer, and from August 1998 to October 2000 its CEO, then continued his work in the company and today occupies the position of Cooperation and Licenses Director. This fact was entered in the Trade Register on 25 September 2015.
Annexes
FileDescription
Uvedomlenie prokurist - 28.09.2015 ENG.docCurrent report 91 - Notification
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2015-09-28Ognian DonevExecutive director